# Acute Effectiveness of Additional Drugs to the Standard Treatment of Depression

> **NCT00001483** · PHASE2 · COMPLETED · sponsor: **National Institute of Mental Health (NIMH)** · enrollment: 75 (—)

## Conditions studied

- Bipolar Disorder
- Depressive Disorder

## Interventions

- **DRUG:** buproprion (Wellbutrin)
- **DRUG:** sertraline (Zoloft)
- **DRUG:** venlafaxine (Effexor)

## Key facts

- **NCT ID:** NCT00001483
- **Lead sponsor:** National Institute of Mental Health (NIMH)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1995-06
- **Primary completion:** —
- **Final completion:** 2002-05
- **Target enrollment:** 75 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001483

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001483, "Acute Effectiveness of Additional Drugs to the Standard Treatment of Depression". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00001483. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*